These data demonstrate that inhibiting osteoclastic activation via anti-RANKL reduces overall fibrotic burden, implicating POLCs in the pathogenesis of silica induced pulmonary fibrosis. The gene discussed is TNFSF11; the disease is pulmonary fibrosis.